XML 35 R23.htm IDEA: XBRL DOCUMENT v3.8.0.1
Research and Development
6 Months Ended
Mar. 01, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Research and Development
Research and Development

We share the cost of certain product and process development activities with development partners. Our R&D expenses were reduced by reimbursements under these arrangements of $58 million and $114 million for the second quarter and first six months of 2018, respectively, and $59 million and $115 million for the second quarter and first six months of 2017, respectively.